Durable humoral responses after the second anti-SARS-CoV-2 vaccine dose in chronic myeloid leukaemia patients on tyrosine kinase inhibitors. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bjh.18001
PubMed Identifier: 34923623
Publication URI: http://europepmc.org/abstract/MED/34923623
Type: Journal Article/Review
Volume: 197
Parent Publication: British journal of haematology
Issue: 1
ISSN: 0007-1048